Methylgene's PIPE Round

Methylgene raised a round of funding on May 04, 2006.

TSE: MYG Biopharmaceutical company focused on the discovery, development and commercialization of novel enzyme inhibitors for the treatment of cancer and infectious diseases. The company uses function…

Articles about Methylgene's PIPE Round: